Food industry opposes proposed front-of-pack warning labels
LAHORE: Stakeholders from Pakistan's packaged food industry expressed serious concerns over a recent proposal 'adoption of nutrient profile models and front-of-pack warning labelling for public health in Pakistan', and urged the Ministry of Science and Technology (MoST) to initiate meaningful consultations with industry representatives before implementing the proposal.
According to industry sources, the Ministry of National Health Services, Regulations and Coordination, through the Pakistan Standards and Quality Control Authority (PSQCA) under the MoST, has introduced a proposal mandating front-of-pack warning labels on all packaged food and beverage products sold in the country.
Industry bodies including the Pakistan Association of Food Industries (PAFI), Pakistan Dairy Association, and the Fruit Juice Council, among others, have expressed their reservations in formal letters addressed to the Ministry. They argue that packaged food accounts for only 10–15% of the market in Pakistan, while the remaining majority consists of unpackaged, non-traceable, often adulterated, and unsafe food products.
The Overseas Investors Chamber of Commerce and Industry (OICCI) and the Pakistan Business Council (PBC) also in their separate correspondence with the Ministry supported the plea of the industry to sort out the issue through consultations.
They emphasize that the packaged food industry in Pakistan delivers safe, high-quality, nutritious, and traceable food in accordance with international standards. Labels on packaged products already include detailed nutritional information - such as fat, carbohydrates, sugar, fiber, proteins, sodium, energy, vitamins, and minerals - per 100g/100ml or per serving, aligned with international benchmarks like the Codex Alimentarius. This transparency, they said, is not available with loose or unpackaged food items, leaving consumers less informed about their dietary choices.
The PAFI, which represents a significant segment of Pakistan's food and beverage industry, stated that its members collectively generate an annual turnover exceeding PKR 1,000 billion, contribute over PKR 200 billion in taxes, and provide employment to more than 100,000 individuals across the country. The sector also supports allied industries such as packaging, logistics, and retail, and plays a key role in earning foreign exchange through exports.
The industry stakeholders contend that the proposed Front-of-Pack Warning Labelling (FOPWL) policy could have unintended consequences—potentially discouraging the consumption of regulated, safe, and traceable packaged foods in favour of unregulated and potentially hazardous alternatives. They stress that Pakistan's primary food-related challenges lie in ensuring food security, safety, and quality, and argue that penalizing the regulated segment of the market could undermine public health goals and foster unfair trade practices.
The industry sources alleged that change of label requires at least six months so as industry can consume its previously printed labels and go for the new ones. While change of label also requires consultation with the stakeholders but the government quarters are trying to ignore all the legal requirements and wanted to implement the proposal. They stated that two meetings were held on this topic but industry was not given proper time to deliberate on this matter and put forth its point of view.
'We believe that collaboration is essential,' stated a representative. 'We request a meeting with the Ministry at the earliest opportunity to discuss our concerns and work together on developing effective, science-based solutions that prioritize consumer well-being without jeopardizing the growth and integrity of the packaged food industry.'
Copyright Business Recorder, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
3 days ago
- Business Recorder
Pakistan's vaccine independence: a national imperative
Pakistan stands at a critical crossroads in public health policy. With seven million births annually and a population growth rate of 2.55%, our nation faces an unprecedented challenge in vaccine security that demands immediate and decisive action. The looming withdrawal of GAVI support by 2031 presents not just a crisis, but an opportunity to transform Pakistan into a self-reliant pharmaceutical powerhouse. The stark reality we face The numbers paint a sobering picture of our current vulnerability. Pakistan's complete dependency on donated and discounted vaccine supplies, supported by GAVI, UNICEF, and WHO to the tune of PKR 26 billion annually, masks a deeper structural weakness. When GAVI's support ends in 2031, the financial burden will balloon to PKR 100 billion annually as nearly four times our current federal health budget of PKR 27 billion. This dependency is not merely financial; it represents a fundamental threat to national health security. This isn't just underdevelopment—it's a systematic surrender of national health autonomy. Today, Pakistan produces virtually no antigens for the Expanded Programme on Immunization (EPI) vaccines domestically. We lack essential seed banks, have minimal university-based vaccine development programs, and operate with regulatory guidelines that are inadequate for sophisticated vaccine manufacturing. Our clinical trial expertise remains severely limited, creating bottlenecks in bringing locally developed vaccines to market. The contrast with global pharmaceutical leaders is stark. While universities worldwide have been the birthplace of revolutionary vaccines-from the Hepatitis B vaccine developed at UC San Francisco to the Oxford-AstraZeneca Covid-19 vaccine-Pakistan's academic institutions remain largely disconnected from commercial vaccine production. Learning from global success stories International experience offers valuable lessons. India transformed itself into the 'pharmacy of the world' through strategic government support for generic manufacturing and robust regulatory frameworks. Singapore built a biomedical hub through integrated research, manufacturing, and regulatory excellence that attracted billions in global pharmaceutical investment. South Korea's government-industry partnerships created world-class biopharmaceutical capabilities. These success stories share common elements: sustained government commitment, strategic investment in infrastructure, regulatory excellence, and comprehensive talent development programs. Most importantly, they demonstrate that with the right approach, developing nations can achieve pharmaceutical self-sufficiency and even become global exporters. The Triple Helix solution The path forward requires unprecedented coordination between government, academia, and industry -what experts call the 'Triple Helix' approach. Each sector must play a distinct yet interconnected role in building national vaccine capacity. Government leadership is essential in creating policy frameworks that incentivize domestic production while providing funding for university research. Strategic assignments to national research institutions like the National Institute of Health, Centre of Excellence in Molecular Biology (CEMB), National Institute for Biotechnology and Genetic Engineering (NIBGE), International Centre for Chemical and Biological sciences (ICCBS), Karachi University, Department of Biotechnology, Dow University of Health Sciences (DUHS), etc., can accelerate vaccine development and establish crucial seed banks. Most critically, the government must develop a comprehensive national health security strategy that positions vaccine self-sufficiency as a matter of national defense. The regulatory transformation cannot be understated. Pakistan's Drug Regulatory Authority must achieve WHO Level 3 qualification and create 'regulatory sandboxes — collaborative environments where university researchers, industry partners, and regulatory experts jointly develop guidelines for the 13 critical EPI vaccine antigens. Fast-track approval pathways and clear regulatory roadmaps will accelerate the journey from laboratory research to commercial production. Formation of sandboxes by bringing together leaders of the University, Regulatory and Industry. Universities must step up as innovation engines. Institutions with BSL-III laboratories should lead development of live attenuated vaccines, while biotechnology departments focus on recombinant vaccine technologies. Specialized vaccine research centers, industry-relevant curricula, and technology transfer offices will bridge the gap between academic discovery and commercial application. State-of-the-art pilot manufacturing facilities will provide proof-of-concept capabilities essential for scaling innovations. Industry brings manufacturing excellence and market expertise to the equation. Private sector partners can transform academic research into GMP-compliant commercial production, establish robust supply chains for raw materials, and navigate complex regulatory approvals. Their distribution networks and market access capabilities will ensure that domestically produced vaccines reach every corner of Pakistan. Leading companies in Pakistan already in the field of Biopharmaceutical manufacturing must be involved in the development process. A realistic implementation roadmap Success requires a phased approach spanning six years. The foundation phase (Years 1-2) must establish policy frameworks and coordination mechanisms while launching capacity-building programmes. Infrastructure development (Years 2-4) involves scaling laboratory manufacturing capabilities, establishing vaccine testing facilities, and launching pilot production programs. The scale-up phase (Years 4-6) transitions to commercial production of EPI vaccines, regulatory approvals, and distribution network establishment. Finally, the optimization phase (Year 6+) expands manufacturing capabilities, develops advanced biologics production, and positions Pakistan as a regional pharmaceutical hub. Financial innovation will be crucial. Blended financing models combining public funding, private investment, and support from institutions like the Islamic Development Bank can mobilise the substantial capital required for drug substance manufacturing facilities. The initial investment may be significant, but the long-term savings and export potential far outweigh the costs. The economic and strategic imperative The benefits extend far beyond health security. A robust domestic vaccine industry could create over 5,000 jobs and reduce import dependency by 50 percent. More importantly, it would establish Pakistan as a regional pharmaceutical hub with significant export potential to neighboring countries and the broader Islamic world. The Covid-19 pandemic demonstrated the critical importance of pharmaceutical self-reliance. Nations with domestic production capabilities could respond rapidly to their populations' needs, while others waited months for external supplies. This lesson cannot be ignored as we face an uncertain global health landscape. The time for action is now Pakistan's demographic dividend — with 65 percent of the population under 30 — represents an unprecedented opportunity to build a knowledge-based pharmaceutical sector. However, this window will not remain open indefinitely. The GAVI deadline of 2031 provides a clear timeline for action, but preparation must begin immediately. The success of this transformation depends on political will, sustained investment, and most importantly, recognition that vaccine self-sufficiency is not a luxury but a national security imperative. Countries that fail to develop domestic pharmaceutical capabilities will remain perpetually vulnerable to supply disruptions, price volatility, and foreign policy pressures. A call to national action The establishment of National and Provincial Coordination Committees bringing together leaders from academia, industry, and regulatory agencies represents the essential first step. This must be followed by a comprehensive assessment of current capabilities, development of a detailed national vaccine strategy, and launch of pilot programmes for immediate impact. Pakistan has the intellectual capital, institutional foundation and market potential to achieve vaccine independence. What we need now is the collective will to transform this potential into reality. The health and prosperity of future generations depend on the decisions we make today. The choice is clear: remain dependent on the goodwill of international donors or invest in building a self-reliant pharmaceutical sector that serves not only Pakistan's needs but positions the nation as a leader in global health innovation. The Triple Helix approach offers a proven pathway to pharmaceutical independence-we must have the courage to take it. Copyright Business Recorder, 2025
Business Recorder
3 days ago
- Business Recorder
HCSTSI suggests targeted relief steps to boost economy
HYDERABAD: The President of Hyderabad Chamber of Small Traders & Small Industry (HCSTSI), Muhammad Saleem Memon, has formally submitted comprehensive budget proposals to the Federal Finance Minister ahead of the Federal Budget 2025–26, urging targeted relief measures for small traders, industrialists, and exporters to boost economic resilience and national growth. Memon emphasised that strengthening the business sector especially SMEs is vital to ensuring long-term economic stability. He stated that this is a critical opportunity for the government to stand firmly with the business community, especially amid ongoing tensions with neighbouring India, and send a strong message of national unity and economic strength to the global community. He stressed the urgent need to empower SMEs by maintaining tax exemptions on solar and wind energy, and by granting subsidies on electricity and gas tariffs. These measures, he explained, would help lower production costs and make Pakistani goods more competitive in international markets. To further support the sector, he called for easy access to low-interest loans, skill development He asked to allocate funds for the rehabilitation of SITE Area Hyderabad, especially road repairs, drainage, and water supply systems. He recommended a notable reduction in interest rates to encourage industrial growth and new ventures. On the export front, he proposed relaxing advance tax requirements, introducing export development schemes, and improving access to untapped global markets. He emphasised expansion of youth-focused vocational training and suggested tax incentives to foster innovation, research, and digital transformation to align Pakistan's industry with global standards. Memon also called for launching microfinance schemes and credit guarantee programs to promote financial inclusion. He strongly advocated for simplifying tax systems, licensing, and business registration to restore business confidence and foster government-business cooperation. A major highlight of his proposal was the demand to revise the mandatory POS registration threshold for small businesses. He recommended increasing the limit to PKR 350,000 monthly or PKR 70 million annually, protecting small traders from undue pressure. To broaden the tax net, he advised compulsory registration of distributors, dealers, and large retailers, along with identifying non-filers through property ownership, foreign travel, and luxury expenditures such as elite school fees. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
12 cities nationwide: JazzCash facilitating QR-based payments at 27 cattle markets
ISLAMABAD: JazzCash is facilitating QR-based payments at 27 cattle markets across 12 cities nationwide -- initiative replaces traditional cash transactions with seamless digital payments, ensuring safety, transparency, and convenience for cattle farmers, merchants, and buyers alike. Following its success last year—facilitating the most widespread interoperable RAAST QR digital payments campaign and contributing over one-third of all QR transactions in the industry—JazzCash is once again enabling secure, efficient, and cashless transactions during this Eidul Azha season. In line with the State Bank of Pakistan's vision to promote digital financial inclusion, JazzCash is facilitating QR-based payments at 27 cattle markets across 12 cities nationwide. This initiative replaces traditional cash transactions with seamless digital payments, ensuring safety, transparency, and convenience for cattle farmers, merchants, and buyers alike. The project aims to integrate rural and semi-urban communities into the digital economy, expanding access to essential financial services and fostering economic empowerment. Adding to its innovative offerings, JazzCash has partnered with Saylani Welfare Trust to launch a digital Qurbani service through the JazzCash app. This service allows customers to conveniently select their preferred Eid day and pickup location or opt to have the meat distributed on their behalf, making the Qurbani process more accessible and hassle-free. JazzCash hosts over 22 million RAAST IDs and an extensive network of more than 535,000 merchants. The platform facilitates the digitization of over PKR 20 billion in QR transactions every month, underscoring its pivotal role in driving the adoption of RAAST payments and advancing Pakistan's fintech landscape. 'JazzCash is committed to empowering communities by making digital payments accessible, secure, and convenient. Our initiatives during this EidulAzha season reflect our dedication to financial inclusion, helping Pakistanis embrace the benefits of a digital economy,' said Khayyam Siddiqi, Head of Communication, JazzCash. JazzCash, Pakistan's leading fintech platform serving nearly 50 million customers, continues to spearhead the country's digital payment revolution, he added. Copyright Business Recorder, 2025
